Back to search
CCUS Clonal Cytopenia of Undetermined Significance
Clinical trial pipeline · Data from ClinicalTrials.gov
See which CCUS Clonal Cytopenia of Undetermined Significance trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which CCUS Clonal Cytopenia of Undetermined Significance trials you may qualify forThis research is being done to find out more about the potential risks and benefits of early treatment in participants with high risk Clonal Cytopenia of Unknow…
This study is being done to investigate clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian or other solid cancers. Researchers…
This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or does n…
Patients with clonal cytopenia of undetermined significance (CCUS) and lower-risk myelodysplastic syndromes (MDS) have a life expectancy of 5 to 10 years. Morta…
Background: Clonal Hematopoiesis of Indeterminate Potential (CHIP) is a change in a person s DNA that can increase a person s risk of developing blood cancers…
This phase II trial evaluates how a curcumin supplement (C3 complex/Bioperine) changes the inflammatory response and symptomatology in patients with clonal cyto…
A registry for the study of the epidemiology, clinical course, and progression of myelodysplastic neoplasms (MDS), myelodysplastic/myeloproliferative neoplasms…
This cross-sectional prevalence assessment study involves a single blood draw in specific patient populations to assess for enzymatic and genomic evidence for a…
Clonal hematopoiesis (CH) is characterized by the overproduction of blood cells derived from a single hematopoietic stem and progenitor cell (HSPC) harboring ce…